Law firm Cyril Amarchand Mangaldas assists with Godrej Astec LifeSciences' ₹238 crore share offering
Cyril Amarchand Mangaldas Advises Godrej Astec LifeSciences on ₹238.2 Crore Rights Issue
Godrej Astec LifeSciences, a subsidiary of Godrej Agrovet, has received legal advice for their ₹238.2 crore (INR 2,382 million) rights issue of equity shares from the law firm Cyril Amarchand Mangaldas. The key team members from Cyril Amarchand Mangaldas who led this advisory were Yash Ashar and Devaki Mankad.
Godrej Astec LifeSciences is a prominent player in the production of agrochemicals, with over 150 reactors in operation. The company manufactures and distributes a wide variety of agrochemical active ingredients and pharmaceutical intermediates. They are significant players in the production of Triazole Fungicides, Herbicides, and Insecticides.
The company's operations cover the manufacturing and distribution of agrochemicals and pharmaceuticals. They operate from nine manufacturing units and have an extensive infrastructure. In addition to their agrochemical products, Godrej Astec LifeSciences also produces a range of intermediates for the pharmaceutical sector.
The transaction was led by Yash J. Ashar (Senior Partner), Devaki Mankad (Partner, Regional Co-Head - Capital Markets - West), and Abhyuday Bhotika (Partner). Veena Raghav (Senior Associate Designate), Anna Kallivayalil (Associate), and Mahima Aggarwal (Associate) provided support in the transaction.
[1] Source: Cyril Amarchand Mangaldas Press Release, dated 27th May 2021.
Investing in Godrej Astec LifeSciences' rights issue could be a decision for those interested in the company's growth due to its significant role in the production of various agrochemicals and pharmaceutical intermediates. Strategically, this move could align with broader business interests involving real-estate, finance, and the chemical industry.
With Cyril Amarchand Mangaldas advising on the rights issue, the transaction honors professionalism and attention to detail, assuring potential investors in the realm of their business and finance activities.
